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Immunoflu.OI.'escent studies a re currently being done on pati ents wi th pemphigus, pemphi -
go id , ~ermat l ~ l s, lupus erythematosus and its variants, the cuta neous prophyrias, sca rrin g 
a lopec ia, eros ive mou th leSIOns, li ght-se nsit ive di sorders, and cuta neous vasculiti s. In this 
paper I sha ll rev iew som~ of the recent advan ces in immunopathology a nd report the resul ts 
that have been obta ll1ed 111 our laboratory. 
PEMPHIGUS 
Pem phigus is a clinica lly, hi stologica lly, and 
immunologically distinctive bullous di sorder which 
involves the epidermis a nd mucous membranes. 
Beutner and Jordon [1] first demonstrated cir-
culat ing antibodies against antigen(s) in the inter-
cellular substance of stratified squamous epi -
thelium, and other investigators soon verified 
these findings [2- 6]. P emphigus ant ibody is com -
posed of a ll four IgG subclasses, a lthough to 
date none of the ant ibod ies has been found 
capable of complement fixation [7]. Its specifi c 
antigen is unknown. Has him oto and co-workers 
[8 ] Suggested that pemphigus antibody is directed 
against a specific carbohydrate moiety or moieties 
in the glycocalyx of the human ep idermis. The 
antibody may occur in low titer for as long as 
one year before the onset of bullous lesions 
[9 ]. In genera l, ant ibody t iter is related to di -
ease activity a nd is a uSP-ful therapeutic gu id e 
[10 ]. The presence of the antibody and its rela-
tionship to pathogenes is is either a primary or a 
secondary event. Antibody to intercellular sub-
stance antibodies has been reported , for example, 
in contagious Brazilian pemphigus fo liaceous and 
in burn patients. Theil' presence in such instances 
suggests that the ant ibodies a re secondary to 
the disease. 
Occasionally pemphigus antibody cannot be 
demonstrated in active disease [lll. Poss ibl e 
causes for this " fa lse negative" reaction include 
species or organ specificity of t he ant ibody, a 
prozone phenom enon, in terference by other reac -
t ive ant ibod ies in the patien t's era, or errors in 
technique . The presence of antinuclear factor in 
particular, is a comm on cause for fa ilure to dem'on-
strate antibody [1 2]. 
Weak ly positive reactions for in terce llula r ant i-
body have been reported in burns [13, 14], Tricho-
phyton rubrum infection [15 ], myasthenia grav is 
[9], lupus erythematosus [9], tox ic ep iderm al ne-
crolysis, drug sens itiv ities [15 ], and morbilliform 
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penicillin eruption [16]. When a spec ific known 
an tige n, such as t ri chophytin, is responsible, a b-
sorption with the antigen removes t he in terce ll u la r 
ant ibody from t he serum [15 ]. 
We have studied sera from 90 patients whose 
di agnos is was pemphigus vulgaris (Tab. I) . In 70 of 
these patients (82.2%), we were ab le to demon-
strate pemphigus antibody. 1 egative resul ts we re 
obtained from patients with inactive or minimal 
di sease, ora l les ions a lone, or from t hose who ha d 
only one or two specimens exa mined . Patients 
followed seria lly demonstrated ant ibodies at some 
t ime in the course of their disease. In tercellular 
substance antibody was demonstrated in 3 of 6 
patien ts with pemphigus foliaceous (Tab. I). 
Direct immunofluorescence of sk in biops ies ha 
demonstrated in vivo depos it ions of immunocrlobu-
lins, primarily G, and complemen t in the i nt ra-
cellular space [17 ]. Depos it ions occur in both le-
sions and norma l skin adjacent to the les ions [12, 
18 ]. Immunopathologic studies of biopsy mate ri a l 
are usually more sensit ive di agnost ica lly than th e 
sero lo~ i c studies and are pos it ive in a pprox imate ly 
90% of the pat ients. We have studied biopsies from 
45 pa t ients whose diagnos is was pemphigus vul -
gans. and demonstrated immunoglobulins, pre-
domll1an tly G, in the in terce llul ar space in 4 1 
(91. 1%) (Tab. I). S imi lar antibodies were demon-
strated in 3 of 6 patients with pemphigus foli a-
ceous. In addition to skin , mucoLls membra ne 
including gingiva, tongue, esophagus, rectum , and 
the cornea, I~ a~ show depos ition of the ant ibody . 
Oral mucosa IS frequent ly II1volved in pemphigu . 
The characterist ic pathology of pemph i!!tls is 
difficul t 0 1' impos ible to demonstrate in pa"tients 
w~th only erosive mouth lesions. Many pat ients 
With pemphigus ini t iall y have only ora lI e ions and 
direct immunofluorescence of Tzanck smears' [19 J 
01' ora l mucosa is useful diagnostica lly (F ig. 1). 
l!sua lly circulatin g ant ibodi es are absent in pa -
t ients with only ora l les ions. In 4 pa t ients. the di ag-
nos is of pemphigus was ini t ia lly made by the im-
munopathology of normal mucosa adjacent to an 
oral erosion. 
Demonstrat ion of bound interce llul ar substance 
ant ibody is unusual in the a b ence of pemphigus. 
After burn injmy in vivo, bound IgG and C3 were 
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TABLE l. Immunopatho logy 
Direct immunofluorescence Indirect immunofluorescence 
Diagnosis Pat ients Positive % Patients' Positive biopsied sera stud ied % 
Pemphi~us 
Pemphi gus vulga ris 45 41 91 90 70 82 
Pemphigus foliaceous 6 3 50 6 3 50 
Pemphi gus erythematosus 2 2 100 2 2 100 
Total 53 46 87 98 75 77 
Pemphi~oid 
Bullous pemphigo id 67 I 
60 
I 
89 
I 
81 58 72 
Cicatricial pemphi goid 16 12 75 18 0" 0 
Dermatitis herpet iformis 
Derm at it is herpetiformis 5] I 32" I 63 I 30 I 0 I a 
" Two patie nts had "pemph igus" antibody and 1 had antibody to in te rcellular space of the lower epithelial cells. 
" IgA . 
FIG. 1. Direct IF staining of biopsy of normal mucosa 
adjacent to oral erosion in a pa tient with pemphigus ( >< 
125). 
d e monstrated in a pe riph e ra l a n t inuclea r pattern 
a nd resembled in terce llul a r an t ibod ies of pem-
phigus [20]. S imil a rly in v ivo bound " periphera l" 
pattern ANA, caused by othe r diseases such as 
lupus erythematosus, can resemble the patte rn of 
pemphigus (6 J (Fig. 2) . 
Rathel' spec ifi c immunopathol ogic findings have 
been dem onstrated in pemphigus erythematosus or 
t he Senear- Usher syndro me [21, 22 ]. M a ny pa-
tients with t his form of pemphigus a lso have lupus 
F IG. 2. Direct IF stall1l11g of a skin biopsy from a 
patient with lupus erythematosus with "peripheral" 
pattern ANA. The in vivo b'inding of ANA resembles the 
pattern of pemphigus ( x 86). 
e rythematos us a nd the immunologic features of 
both pemphigus a nd lupus erythe matosus. Skill 
specimens from cutaneous lupus erythematosu 
les ions show dermoep idermal fluorescence ; pem, 
phigus les ions show inte rce llul a r substance anti, 
body depos ition . Both circul a ting antinuclear anti, 
body a nd in terce llul ar substance antibody may be 
present. We have noted s imi la r findings in 2 
patien ts with Senear- Usher syndrome (Tab. IJ . 
PEMPHIGO ID 
Pemphigoid is cha racterized clinically by large 
te nse b listers and immunolog ically by both circu. 
la ting a nd t issue-fixed an t i basement zone anti· 
bod y . C irculating basem ent membrane zon e anti, 
bodies are present in a majority of patients with 
bullous pem phigoid [6,23-25 ]. 1m m unoglobulins 
a nd comp lem ent are a lso presen t, in v ivo, in 
involved and adjacent uninvolved skin . Bullou 
pe mphigo id a n tibodies fix comp lement [26], 
t hough se rum complement va lues are apparently 
normal. Antibody titer is not close ly related to 
disease activ ity [10). Antibody activ ity in comple. 
ment-i'i x ing pemphigoid se ra is found in a ll four 
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IgG s u bclasses [7) . Both t he classic and alternate 
pathways of compl ement act ivation are ac tivated 
in pe mphigoid [27 ). Ba.se me.nt membrane zone 
antibod y can be elu ted from Il1 vo lved tissue [28 ). 
The a n t ibody perfuses mul t iple in terna l organs 
an d becomes attached to their epi thelial base ment 
membra nes bu t does not ap parent ly ca use sys-
te m ic les ions [7 ). False- pos itive reactions have 
been observed , e.g., in burn patients, but have not 
been reported in clinica lly relevant situations [1 3, 
14 ]. W e h ave demonstrated immunoglobulins, pre-
domin a n t ly IgG, at the dermoepiderm al junction 
in 60 of 67 (89%) pati ents whose diagnos is was 
pemphigoid (T~b . I). Circu lating basem.ent m~m ­
brane zone antibody was demonstrated III 58 of 81 
(72%) patien ts . Sel:a from . inactive or t reated 
patien ts accoun ted for a majori ty of the negative 
results . 
CICATRICIAL PE MPHIGOID 
Cica tricial pemphigoid or mu cous membrane 
pemphigoid, a relat!vely. un~sua l. variant of 
pemphigoid, is an eros ive blI~tenng disease involv-
ing primari ly the mucosa of the mouth and eyes 
which can progress to permanent scarring of the 
conjunctiva a nd blindness . Cuta neous blisters oc-
cur in about one-third of the pat ients. It probably 
is distin ct from bu llolls pemphigoid. Hardy, 
Perry, Pingree, and l( irby [29 ) rev iewed the clini -
cal fea tures in 81 patients. Histo logica lly, the 
blister is sube.pidermal. In most reported cases 
of cicatricial pemphigoid , in vivo bound IgG and 
complement are present in the basement mem-
bra ne zone in involved skin and mucous membrane. 
However, c irculating ant ibodies to epidermal com-
ponen ts have only rarely been detected [30- 35 ). 
We recent ly reported th e immunopathology of 12 
cases of mucous membrane pemphigo id [36). Cur-
ren t ly, we have demonstrated depos ition of im-
munogobi.llins or complement near the base men t 
membrane in 12 of 16 patients with cicatri cial 
pemphigoid (Tab. D. None of the sera from 18 
patien ts showed circulating antibodies of the 
bullous pemphigoid type. The sera of 1 pat ient 
demonstrated circulating antibodies that were ap-
parently bound to the in terce llular space or cy to-
plasm of the lower epi thelia l ce lls. It has been 
suggested that circula ting antibody is present 
only in cicatricial pemphigoid pa tients who al so 
have widespread cutaneous disease [34 ). Two of 
our pat ients had circula ting " pemphigus ant ibody" 
and perhaps should be class ified as having a mixed 
bullous disease. There have been 4 cases of cicatri -
cial pemphi goid in whom circulating pemphigus-
like an t ibodies were demonstrated [37,38 ). 
DERMATITIS HERPETIFORM IS 
Derm ati t is herpe t iform is is a chronic pruri t ic 
vesicular disease. The diagnostic immunofluores-
cent finding is the deposition of IgA at the derma l-
epidermal junction, predominant ly a t the tips of 
the dermal papillae [39- 42 J. Usually t he patte rn of 
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depos it ion is granul ar, t hough fibrillar , homoge-
nous, and mixed de pos its a re occas ionally ob-
served . IgG, IgD, and complement components 
may be presen t . T he immunoglobulin deposits 
a ppear to be on t he reticulin of the dermal papi llae 
[43 J. Norm al skin adjacen t to a ves icle is t he best 
area for biopsy . Seri al sect ions may be necessary to 
demonstra te the IgA depos its. Biopsies of ve icular 
les ions are usually negative [41 J. IgA was demon -
strated in 32 of the 51 (63%) patients wi th derm ati-
t is herpetifo rm is we studied (T ab. I) . Dense de-
posits of fibrin may be fo und in early lesions 
[44,45 J (Fig. 3). Fibrin often can be demonstrated 
before the usual infl amm atory changes are ob-
served histologica lly. 
In derm atitis herpetifor m is, circul ating anti-
bodies to epithelia l components are not presen t 
(T a b. I) . An t ireticulum an t ibodies have been dem-
onstrated in a pprox im ately 20% of t he patients, 
and thyroid , gastric, and antinuclea r an tibodies 
are also increased [46 J. 
Direct immunoflu orescence has a lso shown t hat 
fixed gamm a globul in is present in the basement 
membrane zone of jejuna l mUCosa in derm atit is 
herpetiform is. Circul ati ng an t ibody to the base-
men t membrane zone of jejunal mucosa was also 
found in low titer [46 ]. 
MIXED BULLOUS DISEASE 
Transitional form s between the chronic bullou 
FIG. 3. Direct IF sta ining in bullous derm at it is herpeti-
formis demonstrating deposit ion of fibrin ( x 125). 
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disorders have been reported [47- 49 ]. Honeyman , 
Honeyman , Lobitz, and Storrs [49 ] reported 5 
patients with the clinical , histo logic, t herapeuti c 
response and immunoflu orescence criteri a for both 
dermatit is herpetiform is a nd pemphigo id . van der 
Meer [50) reported a case whi ch clinica ll y was 
dermatit is herpetiformis bu t showed the histo logy 
and immunology of pemphigo id . There is obviously 
an overlapping zone or borderline area between 
derm atitis herpetiformis and bullous pemphigoid . 
In the majority of patien ts, the different iation is 
clear-cut . 
Severa l pat ients have been reported in whom th e 
immunopathology of pemphi gus [51- 54 ] has been 
associated wi t h a blistering erupt ion controll ed by 
sulfapyridine. One, reported by Seah, Fry, Ca irns, 
and Feiwel [52 ], had both in vivo in te rce llul a r 
ant ibodies and circul ating ant ibodies to interce llu -
la r ant igens and had an in t rae piderm a l bull a . 
DeMento and Grover [54 ] used the term "acan-
tholytic herpetiformis dermati t is" to describe a 
simil a r patient wi th features of both pemphigus 
and dermat it is herpetiformis [53 J. Finally, it is not 
surprising to find patients in whom the immuno-
pathologic findings of both pemphigus and pem-
phigoid coexist [55 ]. 
We recently studied 2 pa ti ents wi t h pemphigus 
who had the ty pical features of pemphigus and 
addi t ional circul ating base men t membrane zone 
antibody. Cram , Griffi t h , and Fukuya ma [38 ) 
repor ted 2 patients with cicatricial pemphigo id 
who had circul ating antibodies directed aga inst 
t he intercellular area of epithelium . Their disease 
began with mucosal ul cerat ions and conjunctiva l 
scarring. IgG was bound at the base ment mem -
brane zone of th e involved t issue. Though an 
occas ional patient demonstrates a " mixed bullous 
disease" pattern , these cases are most unusua l and 
do not lessen t he va lue of immunopathology in the 
work -up of a patient wi th a blistering diso rder. 
OTHER BULLOUS DISEASES 
Herpes gestation is is a rare bullous derm atos is of 
pregnancy and the puerperium whose immunopa-
thology is as yet ill defined . Heid , Maleville , and 
Basse [56 ) demonstrated the deposit ion of IgA, a 
feature of derm at.it is herpetiform is. However, 
P rovost and T omasi [57] described 2 patients wit h 
herpes gestation is in whom properdin and C3 
immunoglobulins were demonstra ted in the base-
ment membrane zone. These findin gs implied 
activa tion of only the al ternate pa thway of comple-
ment activation . More recent ly Bushkell , J ordon, 
and Goltz [58 ) demonstra ted C3, properdin , Clq , 
and IgG in a pemphigoid pat tern . This indica ted 
ac tivation of both the alterna te and cl assic path -
ways. Their patient also had a circulating base-
ment membrane zone IgG antibody. Their findin gs 
suggested that herpes gestation is is pa thogenica ll y 
closely rel ated to bullous pemphigus. 
Antibodies to epitheli a l antigens are usua lly not 
present in erythema multiforme. Large num bel'S of 
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immunocytes conta ining IgG , IgM , and comple-
ment can be seen in t he dermis at the base of a 
blister. Some patients, clinicall y di agnosed as 
having chroni c erythema multiform e, have the 
immunofluorescent findin gs of pemphigoid. Lev-
er's [59 ] t heo ry that in so me instances pem phigoid 
may represent chronic erythema mul t iforme IS 
proba bly va lid . 
LUPUS ERYTH EMATOSUS 
The immunohistochemi stry of skin in lupus 
erythematosus (LE) is useful di agnostica lly and 
prognostica lly . S in ce 1967 numerous worker have 
a ppli ed immun oflu orescen t techniqu es to the 
study of cutaneous lupus [60- 66 ]. The presence of 
immunoglobulins, predomin antl y IgG, and com-
pl ement components in the derm al- epidermal 
jun ction has been a cha rac teri stic findin g. Homog-
enous, granul ar , and thready patterns of deposi-
tion have been observed [61 ,67 ] (Fig. 4) . Assoc i-
at ed fibrin accumula tions a re commonly found 
[45 ]. Rothfi eld , Ross, Min ta, and Lepow [68 ] a lso 
demonstrated properdin by indirect immuno£1uo. 
rescence in cuta neous sys temic lupus ery. 
t hematosus (SLE) , suggesting that the a lternate 
pathway of complemen t activat ion is a l 0 invo lved 
in the pathologic changes . Provost, P ass, and 
T omas i (69 ) veri fied these findin gs . C4 has beel) 
rout inely demonstra ted . Thus, both the a lternate 
FIG. 4. Direc t IF' staining of a sca lp biopsy from I 
pa tient wiLh scarring a lopec ia du e LO lupus er)' 
thematosus ( x 125). 
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and classic pathways of complement act ivat ion 
function in LE. 
The characte ri st ic immunopathologic findin g 
in systemic LE are seen in both clini ca lly ::n orm ~ l :: 
k' and cutaneous leS IOns, whereas 111 di SCOid ~~nonlY biopsies from l esi~ns are .positive [64,65, 
67 ]. Our current data on patients With LE a re given 
in Table II. 
The immunoflu orescen t pattern can be diagnos-
tically helpful in different iating ~E from . other 
cutaneous di sorders which a re clllll ca lly Imil a r 
[70,7 1]. Direct im ~ unofluorescence to demon -
strate depOS itIOn of IgG or complement at t he 
dermoep id ermal zone,. in our expe ri ence, has been 
negative in t he followll1g patients: contact derm a-
t it is (10); drug eruptions (20); vi~ il igo (8):. po ly-
morph ic ligh t eruptIOns (38 negative . 2 pos itive); 
pse udopelade (5); psori as is (16); lymphocytic infil -
trate of Jessn er (5); sarcoid (4); li chen planus (30); 
morphea (10); se borrheic derm at itis (7). Tv~'o pa -
tients with lymp hocyto ma CutiS had IgG 111 t he 
infiltrating lymphocytes. Base ment membrane 
zone d epos it ions are a lso absent in our expe rience 
in the following connective t issue di seases: rheu-
matoid arthr iti s (20); scleroderma (45); der-
matomyositis (1l); nephrosis (12); glomeru lone-
phritis (15). 
Moreover, direct immunofluorescence is more 
sensitive and more specific in different iat ing lupu s 
fro m most of these conditions than routine histo-
logic stud ies of a . biops'y spe~im ~n . In ~dd!tion , 
imm unohistochemistry IS useful 111 conf lrmll1g a 
diagnosis of SLE in patients without cutaneous 
lesions. 
The prognosti c va lue of immunopathologic stud -
ies of LE skin is as yet uncerta in . Burnha m , 
eblett, and Fine [72 ] found t hat kidney involve-
ment occurred t hree t imes more frequently in SLE 
patients with posit ive " band " tests from clinica ll y 
normal skins th an in pat ients with negat ive tests. 
Caperton, Bean , and Dick [73 ], on the cont ra ry, 
reported no correl at ion between the presence of 
immune deposits in skin and the seve ri ty of rena l 
disease. However, G illi am, Cheatum , Hurd , and 
Ziff [74 ], in a more comprehensive study, found 
that 17 of 18 patients (94%) with low serum 
complement had cutaneous immune depos its and 
TABLE II. Direct immunofluorescence in lupus 
erythematosu.~ 
Clinical di al(nosis Bi,?psy Number Percenl speClrnens pos iti ve posit ive 
Systemic lupus 
erythematosus 
Involved skin 189 176 93 
Uninvolved skin 193 94 49 
Discoid lupus 
erythematosus 
Involved skin 274 257 94 
Uninvolved sk in 62 0 0 
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15 of 21 pat ients or 71% wi th ren a l disease had 
immune deposits. In ou r cl ini c, when cutaneous 
les ions a re absent. t he exposed skin of the forearm 
is biops ied for di agnostic purposes and uninvolved , 
unexposed skin is b iopsied for prognostic purposes. 
We are current ly eva lu ating our d ata. Our impres-
sion is that depos ition of immune complexes in 
normal skin is corre lated wi t h a high incidence of 
renal di sease. 
The pathogenes is of t he immunopatholog ic find -
ings in cutaneous LE has been extensively studied. 
Acid elu tion tec hniques, u t ili z ing t he fact that 
antigen- antibody complexes di soc iate at an ac id 
pH (3 .0- 3.5 ), are used . Both antinuclear and 
an t iba ement membrane antibodies have been 
elu ted from the skin of patien ts wi th LE [75- 77 ]. 
Therefore both circulating ant igen- antibody com -
plexes and basement membra ne antibodies are 
t hought to playa role in the pathogenes is of t he 
dermoepidermal deposits [76 ]. However , circulat-
ing basement mem brane a ntibodies have not been 
demon stra ted in pa ti ents wi t h lupus ery -
thematosus. 
There is no apparent correlation between anti -
nuclear antibody titer and the in tensity of the 
depos its [64,67 ]. They are usually present, t hough 
diminished, after steroid t hera py [78,79 ]. Occa-
sionally, fixation of antinuclear bodies can be 
demonstrated by immunofluorescence in vivo [65 ] 
(Fig. 5). T his findin g, whose clinica l significance is 
not yet known , is not an artifact, as some have 
stated, since in our experience the same patients 
show the sa me phenomenon re peatedly. McCoy 
[80] a lso described nuclea r depos ition of IgG and 
IgM in 6 of 19 rena l biops ies in lupus nephritis. In 
t he la rgest reported se ries on th is ques tion , Baart 
de la Fa ille-Kuyper [81 ] demonstrated in vivo 
nuclear loca li za tion in 9 of 153 biops ies of unin -
vo lved skin in SLE and in 9 of 10 pat ients with 
proca ina mide-induced LE, aga in from uninvolved 
skin. The in vivo nuclea r loca li za tion did not 
correla te with the leve l of an t inuclea r antibody. 
Occas iona ll y dermoepiderm a l flu orescence from 
t he depos it ion of immunoglobulins has a lso been 
reported and , rarely, in other di seases such as 
rosacea, fac ia l te langiectas ia , derm atomyos it is 
(82 ), autoimmune thyroidi t is [83 ], co ld agglutinin 
sY~ldrome [83 ], chronic biologic fa lse-pos itive reac-
tions [83 ], and wi t h IgM in lepromatou leprosy 
[84 ]. Our data on diseases other t han LE are li sted 
in Table III. The findin gs of most of t hese condi -
t ions are di scussed elsewhere in this paper. Rosa-
cea wi t h a ]:)os itive " band " test can be distin -
guished from LE by a therapeut ic t ri a l of tetracy-
cline. For three years, we have followed 2 "serolog ic 
lupus" patients, who had no clini ca l s igns or 
symptoms, but pos it ive ANA, LE ce ll prepara-
tions, ra ise-pos itive serolog ic tests for syphilis, and 
depo ition of IgG and compleme nt in the dermo-
epiderm a l zone. Dermoe piderm a l complexes a re 
found rare ly in pat ients wi t h procainamide-
induced LE [81] (Fig. 6) but not in patients with a 
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FIG. 5. Direct IF staining of uninvolved skin from a 
patient with systemic lupus erythematosus demonstrat-
ing in vi vo fi xat ion of antinuclear ant ibody ( X 280) . 
TABL E III . Other patients with deposition of 
im munoglobulins in the dermoepiderma/ junction 
Clin ica l diagnos is Num her Numher 
s tudied positive · 
Cuta neous porphyria 50 43 
Polymorphi c li ght eruption 40 2 
Rosacea 10 3 
Leprosy 2 2" 
Amyloid 4 1 
False-positive STS 6 1 
Hypocomplemenlemi c vasculitis 5 3 
"Serolog ic L E" 2 2 
Facial telangiectas ia 3 
a Predo minately IgM. 
pos it ive AN A in the absence of LE. Derm oe pider-
ma l depos it ion of IgG is comm onl y found in t he 
cu taneous prophyri as and pemphigo id . 
Other immunopatholog ic findin gs have been 
repo rted in cutaneo us lu pus. Ovoid " hya lin " 
bodies a re often found in t he epidermis and s ube pi -
derm a l pap ill ary reg ions [65 ,85,86 ]. T hey are not 
spec ifi c for LE and a re frequ en t ly seen in other 
d iseases, part icul a rly li chen pla nus and der-
m ato myositis, and occas iona ll y in norm a l skin. 
T hese aggregates in LE m ay co rrespond to hema-
toxy lin bodi es [65,85 ]. De posit ion of.' immune com -
pl exes in blood vesse ls has a lso been observed 
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[65,87- 90] . In a series of our pa tients wi t h exten-
s ive cutaneous vasculitis, IgG was d emonstra ted in 
involved vessels in 10 of 12 pat ients and C3 in 9 of 
12 (89 ]. 
T he use of horseradish perox idase as a n alterna-
t ive for flu orescein in immunohistochemical label-
in g in LE has been most useful in our la boratory 
[91 ]. Electron microscopy, u t ili zing peroxidase-
la beled an t ibody, has d emonstrated t hat t he an t i-
body aggrega tes in cu ta neous lupus a re found in 
t he sub-basa l la mina l regions of the d ermoe pider-
m a l junct ion. They have a lso been observed in 
s ubendotheli a l al'eas oJ sm a ll blood vessels and 
occasiona lly on coll agen fi brils [92 ]. 
LIC HE N PLANUS 
Immunoglobulins are present in t he form of 
"su bepiderm a l clumps" at the d erma l- epiderma l 
in terface in over 95% of li chen planus lesions [93 ]. 
Th e demonstration of immunoglobulins, par t icu -
la rly in t he pa pill a ry d erm is near t he dermoepider_ 
m al juncti on , can be of a id to the clinic ian [85,92, 
93 ] and should poin t to the di agnosis of lichen 
p lanus. These findin gs are by no means specific. 
T he clumps con ta in IgG, IgM , IgA, C lq , C3, C4, 
C5, complement, and fibrin [93 ]. Baart de la 
Fa ill e-Kuy per demonstrated fibrin and IgM in a ll 
40 li chen pla nus les ions examined [94 ] (Fig. 7). 
FIG. 6. Direct IF sta ining of involved skin in a patient 
with procainamide- induced lupus erythematosus. Usu. 
ally skin biopsies from patients with proca inamide lupu; 
are negative ( x 280) . 
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S imila r depos its occur occas ionally in other d is-
eases . H oweve r, in complex clinical problems, such 
as sca rring alopec ia and eros ive mouth les ions, 
de p os it ions, such as those seen in li chen planus, 
are he lpful diagnostica lly. We have demonstrated 
"subepiderm al clumps" in 28 of 30 (93%) patien ts 
studied [95 ]. 
Though li chen ni t idus has been clinica lly assoc i-
ated wi th li chen planus, t he immunopathology is 
not rem arka ble . Waisman, Dundon, and Michel 
[93 ] studied 6 patients with negat ive resul ts. 
CUTANEOUS PORPH YRIA 
The immunopathology of cutaneous porphyri a is 
ch a r acteristic [87,88,96 ]. We recently repor ted on 
41 p at ien ts wi th four clinica l vari ants of porphyri a 
[96 ], and 9 other patien ts have been studied (Ta b. 
IV) . 
In involved porphyri c skin , IgG is bound in vivo 
in a nd adjacent to derma l blood vesse ls and at the 
dermoepiderm al zone. Quantita tively the depos i-
t ion va ries, being more in tense in erythropoiet ic 
protoporphyri a than in porphyria cutanea ta rd a 
(peT ). Other immunoglobulins and complement 
are r a rely observed . B iopsies from exposed areas in 
patien ts wi t h active PCT usua ll y are pos it ive, 
whereas the skin from unexposed areas is fre-
quen t ly nega tive. The vasc ul ar flu orescence is 
hom ogeneous and very intense. Base ment mem -
brane zone flu orescence has been observed in a 
fi brillar , granular , and homogenous pattern , bu t it 
is u sually not so obvious as vesse l fluorescence . 
Negative biopsies were obta ined from people wi t h 
in a c t ive disease . P CT and LE frequent ly coexist in 
pat ien ts and the immunopathology of both di seases 
is present [97]. We reported 7 such patients [97 ] 
FiG. 7. Direct IF staining of a lesion of lichen planus 
demonstrating deposition of fibrin ( x 86). 
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and have recent ly seen another . Patients on long-
term tetracycl ine therapy may demonstrate the 
same immunopathology as patients with PCT . 
UTANEOUS VASCULIT IS 
Cutaneous vasculi tis is characte ri zed by crops of 
erythema, ur t icari a, and purpura . T he immunopa-
thology of cutaneous vasculi t is remains poorly 
defin ed despi te some recen t advances. Compo-
nen ts of ant igen- ant ibody complexes have been 
detected in the vessels of patients wi th cutaneous 
vasculi t is by seve ra l workers [98,99 ] (F ig. 8). The 
depos it ion of immune complexes in vessels in 
clinica l vasc uli t is suggests an immunolog ic cause. 
T iming of the biopsy a ppears to be importan t. 
Cutaneous vasculi t is assoc iated wi th depos it ion of 
ant ibody complexes and bacteri a l ant igens have 
a lso been reported in patients with vasc uli t is [100 ]. 
In cryoglobulinemic vasculi t is, globulins of the 
same class as those wi thin the serum cryoglobulins 
were in t he lesions [101] . Some immunopathologic 
studies of vasculi t is have been performed with 
in conclusive resul ts [102- 104 ]; however, depositio n 
of immunoglobulins has been seen in several forms 
of small -vessel vasculi tis including hypersensitiv-
ity angii t is [105 ], mixed cryoglobulinemia [105 ], 
lupus erythematosus [105- 107], and rheumatoid 
arthri t is [108 ]. In polyarterit is nodosa associated 
wi th Austra li an antigen [109 ], ant igen , ant ibodies, 
and complement are fo und in the ar teries. An 
immunofluorescent study of tempora l arteri tis 
demonstrated immunoglobulins in 7 of 15 patien ts 
[llO] . The immunoglobulins were due to both 
circulating immune complexes and ant ibody to 
components of the arteri al wa ll . T hirtee n patients 
wi th Henoch- Schonlein syndrome were studied by 
immunofluorescence [lll] . F ine granular depos its 
of IgA, C3, and C5 were found in vesse ls in all 
specimens and suggested a ltern ate pathway com-
plemen t activation. Schroeter et a l [105] demon-
strated immunoglobulins and complement in 15 of 
26 patients wi th necrotizing vasculi tis and in all 4 
patients wi th livedo va culi tis and 3 patients wit h 
fac ia l granuloma. IgA onl y was presen t in fac ia l 
granuloma. Our resul ts in necrotizing vasculi t is are 
lis ted in T a ble V. 
H YPOCOM PLEMENTEMIA WIT H UHTICAHIAL 
VA ULlT IS 
M cD uffie et a l [ll2 ] and Sa ms [113 ] reported 4 
patien ts wi th recurrent attacks of erythematous, 
ur t icari al, and hemorrhag ic skin les ions assoc iated 
wi th synovit is and abdomin a l distress. Skin biop-
T ABLE IV. Deposition of JgG in porphy ria 
-
Diagnosis Num ber Dermoepidermal Immunoglobulin G of cases junction in vessel walls 
Porphyria cutaneous tarda 42 35 37 
Erythropoietic protoporphyria 5 5 5 
Variegate porphyri a 2 2 2 
Coproporphyria 1 1 1 
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sies demonstrated necrotizing vasculitis. Immuno-
globulins and complement were demonstrated in 
vessel walls in 1 patient. Hypocomplementemia 
was present with low leve ls of both early-reacting 
and late-reacting components of complement dur-
ing attacks. It was felt that t hese patients had a 
hi therto undescribed immune complex disease. 
Recently, it was' reported that this syndrome of 
chronic refractory ur t icaria with arthralgias and 
necrotiz ing vascu li tis may occur with or without 
hypocomplementemia [114). We have observed 5 
similar patients (Fig. 9, Tab. VI). All had persist-
ent urticaria-like les ions which demonstrated ne-
crotizing vasculitis histologica lly. Serologic stud-
ies, including antinuclear antibody LE cell prepa-
rations and DNA, RNA, and ENA ant ibodies , were 
FIG. 8. Direct IF staining or an early lesion or necrotiz-
ing vasculitis demonstrat ing complement (C3) deposition 
( x 125) . 
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negative in all ; 4 of 5 had hypocomplementemia. 
Three of 5 had deposition of IgG and C3 at the 
dermoepidermal zone. Two of the patients also had 
immune complexes in their renal biopsies. These 
patients ap parently have a variant of immune 
complex disease in whom the serologic features of 
lupus erythematosus are not present. 
MISCELLANEOUS FINDINGS 
In 2 patients with toxic epidermolys is due to 
penicillin and chlorpromazine, direct immunofluo-
rescence revealed interce ll ular fixation of IgG and 
C3 confined to the basal layer of the epidermis 
(115). In 2 other patients circulating intercellular 
antibodies were demonstrated [116 ). Shelley , 
Schlappner, and Heiss [117) demonstrated direct 
in tercellular immunofluorescence confined to the 
basal cell and adjacent layers in a patient with a 
fixed bullous eruption due to phenolphthalein. 
Two patients with acquired epidermolysis bullosa 
acquisita demonstrated in vivo IgG and C3 local-
ized in the basement membrane zone [118 ). Circu-
lating antibodies aga inst epidermal cytoplasmic 
TABLE V. Direct immunofluorescence in necrotizing 
vasculitis 
Patients Positi ve Diagnosis biopsied IgG IgM C3 Fibrin 
Necrotizing 35 25 12 15 30 
vasculitis 
FIG. 9. Complement at the dermoepidermal junction it 
the biopsy of the lesion (x 86). 
TABLE VI. Refractory urticaria, necrotizing vasculitis and hypocomplementemia 
Complement values 
ANA DNA RNA ENA LE IgG" C3" Total C2 ~ C4 (114- 120 CH .. (335- 485) (100- 190) (27,000- 73,000) 
1. E.W. - - - ' - - - - 150 50 10,000 95 
2. M.A. - - - - - + + 130 - 15,000 100 
3. W.J. - - - - - + + - 60 - 10 
4. M.D. - - - - - - - - 70 
- 10 
5. V. N. - - - - - + + - 120 - 115 
" Basement membrane direct immunol1uorescence. 
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antigen s were reported in 32% of patients with 
malignant tumors [119] ; t hese antibod ies are fa irly 
common , being present in 17% of normal subjects . 
Burnham [120] reported 2 pa tterns of circulating 
ep iderm a l cytoplasmic an t ibodies, a genera l 
fluorescence of the cytoplasm in the ent ire epider-
mis, and an " upper epidermal cytop lasmic" which 
spared the basal ce ll layer. Alexand er a nd 
StimmJer [1 21 ] reported a patient with der-
matomyos itis and " frizzy" hair who developed 
an t ibodies to ha ir fo lli cles. 
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